OKYO Pharma Limited (NASDAQ: OKYO)’s stock price has gone rise by 14.55 in comparison to its previous close of 1.10, however, the company has experienced a 23.53% increase in its stock price over the last five trading days. proactiveinvestors.com reported 2024-10-26 that OKYO Pharma Ltd (NASDAQ:OKYO) CEO Gary Jacob joined Proactive to discuss recent developments in the company’s Phase 2 clinical trial for OK-101, an investigational therapy targeting neuropathic corneal pain (NCP). Jacob highlighted a significant milestone for the trial: the first patient dosed.
Is It Worth Investing in OKYO Pharma Limited (NASDAQ: OKYO) Right Now?
The 36-month beta value for OKYO is also noteworthy at -0.06.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OKYO is 24.54M, and at present, short sellers hold a 0.76% of that float. The average trading volume of OKYO on October 28, 2024 was 199.87K shares.
OKYO’s Market Performance
OKYO stock saw an increase of 23.53% in the past week, with a monthly gain of 26.00% and a quarterly increase of 0.80%. The volatility ratio for the week is 15.80%, and the volatility levels for the last 30 days are 7.67% for OKYO Pharma Limited (OKYO). The simple moving average for the past 20 days is 20.17% for OKYO’s stock, with a -4.20% simple moving average for the past 200 days.
OKYO Trading at 19.98% from the 50-Day Moving Average
After a stumble in the market that brought OKYO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.57% of loss for the given period.
Volatility was left at 7.67%, however, over the last 30 days, the volatility rate increased by 15.80%, as shares surge +24.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +28.56% upper at present.
During the last 5 trading sessions, OKYO rose by +23.53%, which changed the moving average for the period of 200-days by -25.88% in comparison to the 20-day moving average, which settled at $1.0485. In addition, OKYO Pharma Limited saw -28.81% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for OKYO
The total capital return value is set at 0.0.
Currently, EBITDA for the company is 15745.87 with net debt to EBITDA at 52.51.
Conclusion
In summary, OKYO Pharma Limited (OKYO) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
